These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24472868)

  • 21. Wedge resection of the stomach for gastric leiomyosarcoma.
    Katai H; Sasako M; Sano T; Maruyama K
    Br J Surg; 1997 Apr; 84(4):560-1. PubMed ID: 9112920
    [No Abstract]   [Full Text] [Related]  

  • 22. Principles of surgical treatment for curable gastric cancer.
    Sasako M
    J Clin Oncol; 2003 Dec; 21(23 Suppl):274s-275s. PubMed ID: 14645409
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.
    Saladino E; Fleres F; Mazzeo C; Pruiti V; Scollica M; Rossitto M; Cucinotta E; Macrì A
    Anticancer Res; 2014 Apr; 34(4):2019-22. PubMed ID: 24692741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale.
    Roviello F; Caruso S; Neri A; Marrelli D
    Eur J Surg Oncol; 2013 Dec; 39(12):1309-16. PubMed ID: 24183797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it time to change surgical strategy for gastric cancer in the United States?
    Kappas AM; Fatouros M; Roukos DH
    Ann Surg Oncol; 2004 Aug; 11(8):727-30. PubMed ID: 15249337
    [No Abstract]   [Full Text] [Related]  

  • 26. Slow progress in predicting and preventing fatal gastric cancer peritoneal recurrence.
    Spiliotis J; Halkia E
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S200-1; author reply S202-5. PubMed ID: 21691877
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.
    Kaibara N; Hamazoe R; Iitsuka Y; Maeta M; Koga S
    Hepatogastroenterology; 1989 Apr; 36(2):75-8. PubMed ID: 2499527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
    Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
    Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of stomach cancer surgery].
    Peters H; Langer S; Schubert HJ
    Med Welt; 1982 Feb; 33(6):207-9. PubMed ID: 7070281
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical significance and practice points of conversion therapy for gastric cancer with peritoneal metastasis].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1094-1098. PubMed ID: 29130218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endoscopic mucosal resection].
    Hamada T; Kondo K; Itagaki Y; Kitamura S
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():299-302. PubMed ID: 11424395
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study.
    Misawa K; Mochizuki Y; Ohashi N; Matsui T; Nakayama H; Tsuboi K; Sakai M; Ito S; Morita S; Kodera Y
    Jpn J Clin Oncol; 2014 Jan; 44(1):101-3. PubMed ID: 24287077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy.
    Arita T; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Hiramoto H; Hamada J; Shoda K; Kawaguchi T; Hirajima S; Nagata H; Fujiwara H; Okamoto K; Otsuji E
    Ann Surg Oncol; 2015 Mar; 22(3):758-64. PubMed ID: 25201501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylaxis and treatment of peritoneal metastasis from gastric cancer].
    Kaibara N
    Nihon Geka Gakkai Zasshi; 1996 Apr; 97(4):308-11. PubMed ID: 8692149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.
    Cao L; Selby LV; Hu X; Zhang Y; Janjigian YY; Tang L; Coit DG; Brennan MF; Strong VE
    J Surg Oncol; 2016 Jun; 113(7):745-9. PubMed ID: 27040753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
    Baiocchi GL; Marrelli D; Verlato G; Morgagni P; Giacopuzzi S; Coniglio A; Marchet A; Rosa F; Capponi MG; Di Leo A; Saragoni L; Ansaloni L; Pacelli F; Nitti D; D'Ugo D; Roviello F; Tiberio GA; Giulini SM; De Manzoni G
    Ann Surg Oncol; 2014 Jun; 21(6):2005-11. PubMed ID: 24526547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracing Dissectable Layers of Mesenteries Overcomes Embryologic Restrictions when Performing Infrapyloric Lymphadenectomy in Laparoscopic Gastric Cancer Surgery.
    Shinohara H; Haruta S; Ohkura Y; Udagawa H; Sakai Y
    J Am Coll Surg; 2015 Jun; 220(6):e81-7. PubMed ID: 25998088
    [No Abstract]   [Full Text] [Related]  

  • 38. Colorectal cancer with peritoneal metastases: Progress, not perfection.
    Esquivel J
    J Surg Oncol; 2015 Jul; 112(1):115. PubMed ID: 26153356
    [No Abstract]   [Full Text] [Related]  

  • 39. Gastrectomy for patients with positive peritoneal cytology: comments on the article "Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients".
    Okabe H; Sakai Y
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S211-2; author reply S213-4. PubMed ID: 21484521
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of patients with gastric polyps].
    Kolpakova GI; Golubev VV
    Klin Khir (1962); 1989; (8):61-2. PubMed ID: 2811097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.